IDENTIFICATION OF A NOVEL SIGNAL PATHWAY FOR NGF
NGF 新型信号通路的鉴定
基本信息
- 批准号:6490115
- 负责人:
- 金额:$ 26.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-01-01 至 2003-12-31
- 项目状态:已结题
- 来源:
- 关键词:PC12 cells biological signal transduction cell adhesion cell growth regulation confocal scanning microscopy extracellular matrix gene induction /repression genetically modified animals immunofluorescence technique immunoprecipitation laboratory mouse metalloendopeptidases neurogenesis neurotrophic factors paxillin phosphorylation protein binding protein structure function protein tyrosine kinase receptor coupling regulatory gene tissue /cell culture transfection yeast two hybrid system
项目摘要
Nerve Growth Factor (NGF) is a polypeptide growth factor that plays a
critical role in the differentiation of immature neuroblasts and the
subsequent survival of a subpopulation of mature neurons in both the
peripheral and central nervous systems. NGF initiates its effects by
binding to TrkA, a receptor type tyrosine kinase that when activated,
initiates a signal transduction cascade resulting in Ras activation and
the induction of early response genes. NGF-induced neurite outgrowth
is also accompanied by extensive re-organization of the neuronal
cytoskeleton to initiate neurite extension of neurite processes. Indeed,
while the shape of filopodia and lamella in growth cones is largely
determined by the organization of the actin cytoskeleton, little is
known about how NGF and TrkA signaling is linked to the cytoskeleton.
Over the past few years, we have been studying the Crk adaptor protein
and its role during NGF-induced neuronal differentiation. Upon NGF
addition to PC12 cells or primary dorsal root ganglia neurons, c-Crk is
rapidly tyrosine phosphorylated at tyrosine 222. Interestingly,
overexpression of mutant c-Crk carrying a mutation at Y222 (c-CrkY222F)
impairs NGF-mediated neurite outgrowth in PC12 cells and abolishes TrkA-
induced tyrosine phosphorylation of the cytoskeletal protein Paxillin.
Our results indicate that Crk is involved in a novel aspect of TrkA
signaling to adhesion complexes, thereby regulating actin re-
organization and cell adhesion. In the present application, we shall
study the molecular mechanisms by which c-Crk couples the TrkA receptor
to the cytoskeleton, with the long-term goal to understand how NGF
promotes differentiation and survival. Specifically, we plan to: (i)
determine whether c-CrkY222F is a dominant negative c-Crk protein by
impairing NGF-induced cell adhesion, (ii) determine the circuitry
involved in NGF-induced tyrosine phosphorylation of c-Crk, (iii)
determine the relationship between NGF- and adhesion-induced tyrosine
phosphorylation of the c-Crk effector protein Paxillin, (iv) determine
the biological role of Paxillin during NGF-mediated responses, and (v)
determine the role of c-Crk during neuronal development using transgene
approaches.
神经生长因子(NGF)是一种多肽生长因子,
在未成熟成神经细胞分化中的关键作用,
随后的存活的亚群成熟神经元在这两个
外周和中枢神经系统。 NGF通过以下方式启动其作用:
与TrkA结合,TrkA是一种受体型酪氨酸激酶,当被激活时,
启动导致Ras激活的信号转导级联,
早期反应基因的诱导。 神经生长因子诱导的神经突起生长
也伴随着神经元的广泛重组,
细胞骨架启动神经突突起的神经突延伸。的确,
而生长锥中的丝状伪足和片层的形状主要是
由肌动蛋白细胞骨架的组织决定,
了解NGF和TrkA信号如何与细胞骨架联系。
在过去的几年里,我们一直在研究Crk衔接蛋白,
及其在NGF诱导的神经元分化过程中的作用。 NGF后
除了PC 12细胞或原代背根神经节神经元外,c-Crk还
在酪氨酸222处快速酪氨酸磷酸化。 有趣的是,
携带Y222突变的突变型c-Crk(c-CrkY 222 F)的过表达
在PC 12细胞中损害NGF介导的神经突生长,并消除TrkA-
诱导细胞骨架蛋白桩蛋白的酪氨酸磷酸化。
我们的研究结果表明Crk参与TrkA的一个新方面
信号传导到粘附复合物,从而调节肌动蛋白的再活化。
组织和细胞粘附。 在本申请中,我们将
研究c-Crk与TrkA受体偶联的分子机制
长期目标是了解神经生长因子
促进分化和存活。 具体而言,我们计划:(i)
确定c-CrkY 222 F是否是显性阴性c-Crk蛋白,
损害神经生长因子诱导的细胞粘附,(ii)确定电路
参与NGF诱导的c-Crk酪氨酸磷酸化,(iii)
确定NGF和粘附诱导的酪氨酸之间的关系
(iv)测定c-Crk效应蛋白桩蛋白的磷酸化,
桩蛋白在NGF介导的应答期间的生物学作用,和(v)
利用转基因技术确定c-Crk在神经元发育过程中的作用
接近。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAYMOND B BIRGE其他文献
RAYMOND B BIRGE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAYMOND B BIRGE', 18)}}的其他基金
Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer
靶向磷脂酰丝氨酸/TAM 受体/PD-L1 轴作为癌症的脆弱性
- 批准号:
10554443 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Targeting a phosphatidylserine/TAM receptor/PD-L1 axis as a vulnerability in cancer
靶向磷脂酰丝氨酸/TAM 受体/PD-L1 轴作为癌症的脆弱性
- 批准号:
10365623 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Non-canonical signal pathway for Crk in breast cancer
乳腺癌中 Crk 的非经典信号通路
- 批准号:
8701004 - 财政年份:2012
- 资助金额:
$ 26.84万 - 项目类别:
Non-canonical signal pathway for Crk in breast cancer
乳腺癌中 Crk 的非经典信号通路
- 批准号:
8402232 - 财政年份:2012
- 资助金额:
$ 26.84万 - 项目类别:
Non-canonical signal pathway for Crk in breast cancer
乳腺癌中 Crk 的非经典信号通路
- 批准号:
9246662 - 财政年份:2012
- 资助金额:
$ 26.84万 - 项目类别:
Non-canonical signal pathway for Crk in breast cancer
乳腺癌中 Crk 的非经典信号通路
- 批准号:
8509636 - 财政年份:2012
- 资助金额:
$ 26.84万 - 项目类别:
Targeting FKBP52 and Copper in Alzheimer's Disease
靶向 FKBP52 和铜治疗阿尔茨海默病
- 批准号:
7150136 - 财政年份:2006
- 资助金额:
$ 26.84万 - 项目类别:
Targeting FKBP52 and Copper in Alzheimer's Disease
靶向 FKBP52 和铜治疗阿尔茨海默病
- 批准号:
7270115 - 财政年份:2006
- 资助金额:
$ 26.84万 - 项目类别:
IDENTIFICATION OF A NOVEL SIGNAL PATHWAY FOR NGF
NGF 新型信号通路的鉴定
- 批准号:
6342942 - 财政年份:1999
- 资助金额:
$ 26.84万 - 项目类别:
IDENTIFICATION OF A NOVEL SIGNAL PATHWAY FOR NGF
NGF 新型信号通路的鉴定
- 批准号:
6331057 - 财政年份:1999
- 资助金额:
$ 26.84万 - 项目类别:
相似海外基金
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
6238317 - 财政年份:1997
- 资助金额:
$ 26.84万 - 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
5210031 - 财政年份:
- 资助金额:
$ 26.84万 - 项目类别: